Towards an MMP-2-activated molecular agent for cancer imaging.

Area of Science:

• Biomedical imaging
• Molecular imaging
• Cancer biomarkers

Background:

• Matrix metalloproteinases (MMPs) are implicated as cancer biomarkers.
• Prognostic potential of MMPs in cancer is recognized.
• Lack of non-invasive detection methods for MMPs hinders clinical application.

Purpose of the Study:

• To synthesize a DOTA-containing peptide for non-invasive imaging of MMP-2.
• To develop a probe with selectivity for MMP-2 over other MMPs.
• To enable radiolabeling with 68Gallium or incorporation with gadolinium for MRI.

Main Methods:

• Peptide synthesis incorporating DOTA chelator.
• Radiolabeling with 68Gallium for PET imaging.
• Gadolinium incorporation for MRI contrast agent development.
• Evaluation of MMP-2 selective cleavage of labeled peptides.

Main Results:

• Successful synthesis of a DOTA-containing peptide.
• Demonstrated selective cleavage of the peptide by MMP-2.
• Potential for dual-modality imaging (PET and MRI) applications.

Conclusions:

• The developed peptide is a promising tool for selective MMP-2 detection.
• This approach facilitates non-invasive imaging of MMP-2 as a cancer biomarker.
• The peptide enables targeted imaging for improved cancer diagnosis and prognosis.